Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

December 1, 2025

Study Completion Date

October 1, 2026

Conditions

CirrhosisHepatic Encephalopathy

Interventions

DRUG

Albumin Infusion

Intravenous human serum albumin to be given at 1.5g/kg ideal body weight

Trial Locations (1)

RECRUITING

Hunter Holmes McGuire VA Medical Center, Richmond

All Listed Sponsors

collaborator

Grifols Biologicals, LLC

INDUSTRY

lead

Hunter Holmes Mcguire Veteran Affairs Medical Center

FED

NCT06052176 - Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement | Biotech Hunter | Biotech Hunter